4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-26-082014
Options or other derivatives
- President & CEO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| CARUSO JAMES V President & CEO | 2026-07-07 | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | D | ||
Loading xslF345X06/tm2620095-6_4seq1.xml…